Martine Bagot Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

12/2018	Osteopenia and fractures associated with long-term therapy with MEK inhibitors.
10/2017	Focal necrotizing myopathy with 'dropped-head syndrome' induced by cobimetinib in metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martine Bagot Research Topics

Disease

31	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2024 - 01/2004
23	Melanoma (Melanoma, Malignant) 12/2018 - 10/2006
22	Mycosis Fungoides 04/2024 - 09/2005
21	Neoplasms (Cancer) 01/2022 - 12/2003
8	Lymphoma (Lymphomas) 01/2023 - 06/2006
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 05/2004
5	Skin Diseases (Skin Disease) 03/2024 - 09/2013
5	Exanthema (Rash) 01/2023 - 10/2021
5	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2023 - 04/2002
4	Pyoderma Gangrenosum 01/2023 - 01/2016
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 02/2007
4	Atopic Dermatitis (Atopic Eczema) 01/2023 - 11/2014
4	Infections 01/2023 - 02/2015
4	Localized Scleroderma (Morphea) 10/2022 - 02/2011
4	Cutaneous Lupus Erythematosus 01/2022 - 12/2014
4	Inflammation (Inflammations) 04/2021 - 01/2016
4	Sarcoidosis (Schaumann Disease) 01/2020 - 01/2012
4	Blister (Bulla) 02/2011 - 04/2002
3	Sezary Syndrome (Sezary Erythroderma) 11/2023 - 06/2007
3	Bronchiolitis Obliterans Syndrome 08/2023 - 03/2015
3	Disease Progression 11/2020 - 09/2007
3	Paraproteinemias (Monoclonal Gammopathy) 01/2020 - 06/2013
3	Pain (Aches) 12/2018 - 09/2013
3	Hypersensitivity (Allergy) 06/2017 - 01/2012
2	Kimura Disease 12/2023 - 01/2015
2	Tinea (Ringworm) 01/2022 - 02/2015
2	Urticaria (Hives) 04/2021 - 01/2019
2	Scleromyxedema (Lichen Myxedematosus) 01/2020 - 06/2013
2	Necrobiosis Lipoidica 01/2020 - 01/2019
2	Bullous Pemphigoid (Pemphigoid) 06/2019 - 01/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Sepsis (Septicemia) 01/2018 - 02/2015
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2017 - 06/2010
2	Neoplasm Metastasis (Metastasis) 08/2016 - 02/2014
2	Carcinogenesis 08/2016 - 02/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2016 - 01/2016
2	Granuloma Annulare 02/2016 - 02/2011
2	Diarrhea 01/2016 - 06/2013
2	Colitis 01/2016 - 06/2013
2	Crohn Disease (Crohn's Disease) 01/2016 - 02/2007
2	Burns 02/2011 - 11/2004
2	Exfoliative Dermatitis (Erythroderma) 12/2010 - 02/2008
1	Dermatitis 09/2023
1	Tibial Fractures (Fracture, Tibial) 02/2023

Drug/Important Bio-Agent (IBA)

13	mogamulizumabIBA 01/2023 - 03/2017
10	Monoclonal AntibodiesIBA 01/2022 - 03/2012
8	AntibodiesIBA 01/2021 - 04/2007
7	Rituximab (Mabthera)FDA Link 02/2023 - 03/2009
7	Infliximab (Remicade)FDA Link 01/2019 - 02/2007
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2012
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2004
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 09/2005
6	IpilimumabIBA 01/2017 - 06/2013
5	dupilumabIBA 12/2023 - 09/2020
5	Mechlorethamine (Nitrogen Mustard)FDA Link 09/2023 - 09/2005
5	CytokinesIBA 01/2023 - 11/2004
5	VemurafenibIBA 10/2017 - 10/2012
4	InterferonsIBA 04/2024 - 02/2011
4	Vorinostat FDA Link 01/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 11/2004
4	NivolumabIBA 11/2017 - 05/2016
4	Immune Checkpoint InhibitorsIBA 11/2017 - 05/2016
4	SteroidsIBA 02/2017 - 06/2013
4	plastinIBA 01/2014 - 02/2008
3	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2021
3	Immunoglobulin A (IgA)IBA 04/2021 - 09/2013
3	LigandsIBA 01/2021 - 02/2009
3	KIR3DL2 ReceptorsIBA 08/2018 - 10/2014
3	PerforinIBA 02/2009 - 04/2002
3	AntigensIBA 02/2009 - 12/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 04/2002
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 09/2020
2	EnzymesIBA 11/2021 - 05/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 06/2015
2	Etanercept (Enbrel)FDA Link 01/2019 - 02/2007
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 10/2017
2	CalciumIBA 12/2018 - 01/2014
2	Lenalidomide (CC 5013)FDA Link 01/2018 - 06/2017
2	Interleukin-2 (IL2)IBA 01/2018 - 12/2005
2	liposomal doxorubicin (Doxil)FDA Link 06/2017 - 11/2012
2	pembrolizumabIBA 01/2017 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 08/2016 - 12/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 03/2013
2	Phosphotransferases (Kinase)IBA 12/2015 - 02/2006
2	AllergensIBA 01/2015 - 11/2014
2	Interferon-gamma (Interferon, gamma)IBA 06/2010 - 11/2004
1	Adenosine (Adenocard)FDA LinkGeneric 04/2024
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2024
1	ruxolitinibIBA 08/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023

Therapy/Procedure

27	Therapeutics 03/2024 - 09/2005
9	Immunotherapy 01/2018 - 06/2010
6	Drug Therapy (Chemotherapy) 11/2020 - 03/2009
4	Combination Drug Therapy (Combination Chemotherapy) 02/2023 - 05/2014
3	Aftercare (After-Treatment) 08/2023 - 02/2011
3	Hematopoietic Stem Cell Transplantation 01/2023 - 07/2015
3	Stem Cell Transplantation 02/2017 - 03/2014
2	Duration of Therapy 09/2023 - 01/2018
1	Homologous Transplantation 10/2023